MedTrace Logo

Mobile Application Versus Tell-show-do Technique for Improved Behavior Management of Dental Anxiety in Children Aged 7-11 Years: a Multicenter Randomized Control Trial in Karachi-Pakistan

NCT07553156 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 114

Last updated 2026-04-27

No results posted yet for this study

Summary

This study aims to compare the effectiveness of a mobile application versus the conventional tell-show-do (TSD) technique in reducing dental anxiety among children aged 7-11 years attending their first dental visit. The study is a multicenter randomized controlled trial conducted at tertiary care dental hospitals in Karachi, Pakistan. Participants are randomly assigned to either a mobile application-based behavioral intervention or the TSD technique prior to a dental diagnostic procedure. The primary outcomes include changes in pulse rate and anxiety levels measured using the Raghavendra Madhuri Sujata Pictorial Scale (RMS-PS) before and after the intervention. The findings of this study will help determine whether mobile-based behavioral tools can improve anxiety management in pediatric dental settings.

Conditions

  • Dental Fear and Anxiety
  • Dental Anxiety

Interventions

BEHAVIORAL

Mobile Application

A mobile application-based behavioral intervention is provided for approximately 5 minutes prior to the dental diagnostic procedure to familiarize children with the dental environment and reduce anxiety.

BEHAVIORAL

Tell-Show-Do Technique

The conventional tell-show-do behavioral technique is administered for approximately 5 minutes prior to the dental diagnostic procedure to prepare children and reduce anxiety.

Sponsors & Collaborators

  • Dow University of Health Sciences

    collaborator OTHER

  • Civil Hospital Karachi

    collaborator OTHER_GOV

  • Aga Khan University Hospital, Pakistan

    lead OTHER

Principal Investigators

  • Shafquat Rozi, PhD · Community Health Sciences (CHS), Aga Khan University Hospital (AKUH)

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
7 Years
Max Age
11 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-02-15
Primary Completion
2026-04-20
Completion
2026-04-20

Countries

  • Pakistan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07553156 on ClinicalTrials.gov